JP2022065029A5 - - Google Patents

Download PDF

Info

Publication number
JP2022065029A5
JP2022065029A5 JP2022017513A JP2022017513A JP2022065029A5 JP 2022065029 A5 JP2022065029 A5 JP 2022065029A5 JP 2022017513 A JP2022017513 A JP 2022017513A JP 2022017513 A JP2022017513 A JP 2022017513A JP 2022065029 A5 JP2022065029 A5 JP 2022065029A5
Authority
JP
Japan
Prior art keywords
cells
therapeutic
fucosyltransferase
fucosylated
cryoprotectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022017513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022065029A (ja
Filing date
Publication date
Priority claimed from PCT/US2015/039370 external-priority patent/WO2016007506A1/en
Application filed filed Critical
Publication of JP2022065029A publication Critical patent/JP2022065029A/ja
Publication of JP2022065029A5 publication Critical patent/JP2022065029A5/ja
Priority to JP2024061477A priority Critical patent/JP7788486B2/ja
Pending legal-status Critical Current

Links

JP2022017513A 2014-07-07 2022-02-07 治療的用途のためのフコシル化細胞の製造および凍結保存 Pending JP2022065029A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024061477A JP7788486B2 (ja) 2014-07-07 2024-04-05 治療的用途のためのフコシル化細胞の製造

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462021328P 2014-07-07 2014-07-07
US62/021,328 2014-07-07
PCT/US2015/039370 WO2016007506A1 (en) 2014-07-07 2015-07-07 Manufacture and cryopreservation of fucosylated cells for therapeutic use
JP2016576062A JP2017525340A (ja) 2014-07-07 2015-07-07 治療的用途のためのフコシル化細胞の製造および凍結保存

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016576062A Division JP2017525340A (ja) 2014-07-07 2015-07-07 治療的用途のためのフコシル化細胞の製造および凍結保存

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024061477A Division JP7788486B2 (ja) 2014-07-07 2024-04-05 治療的用途のためのフコシル化細胞の製造

Publications (2)

Publication Number Publication Date
JP2022065029A JP2022065029A (ja) 2022-04-26
JP2022065029A5 true JP2022065029A5 (https=) 2022-12-02

Family

ID=55064767

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016576062A Pending JP2017525340A (ja) 2014-07-07 2015-07-07 治療的用途のためのフコシル化細胞の製造および凍結保存
JP2022017513A Pending JP2022065029A (ja) 2014-07-07 2022-02-07 治療的用途のためのフコシル化細胞の製造および凍結保存
JP2024061477A Active JP7788486B2 (ja) 2014-07-07 2024-04-05 治療的用途のためのフコシル化細胞の製造

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016576062A Pending JP2017525340A (ja) 2014-07-07 2015-07-07 治療的用途のためのフコシル化細胞の製造および凍結保存

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024061477A Active JP7788486B2 (ja) 2014-07-07 2024-04-05 治療的用途のためのフコシル化細胞の製造

Country Status (9)

Country Link
US (3) US20170121673A1 (https=)
EP (1) EP3167046A4 (https=)
JP (3) JP2017525340A (https=)
KR (1) KR102505009B1 (https=)
CN (2) CN106687581A (https=)
AU (2) AU2015288052B2 (https=)
CA (1) CA2954534C (https=)
SG (1) SG11201610699XA (https=)
WO (1) WO2016007506A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332334B2 (en) 2003-04-18 2008-02-19 Oklahoma Medical Research Foundation Hematopoietic stem cells treated by in vitro fucosylation and methods of use
US20140161782A1 (en) 2008-06-09 2014-06-12 Targazyme, Inc. Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucoslytransferase
AU2013204922B2 (en) 2012-12-20 2015-05-14 Celgene Corporation Chimeric antigen receptors
JP6493692B2 (ja) 2013-03-15 2019-04-10 セルジーン コーポレイション 修飾されたｔリンパ球
CA2954534C (en) * 2014-07-07 2023-04-04 Targazyme, Inc. Manufacture and cryopreservation of fucosylated cells for therapeutic use
SG11201705401YA (en) * 2014-12-30 2017-08-30 The Brigham And Women`S Hospital Inc Methods to improve cell therapy
IL309689B1 (en) * 2017-02-28 2026-02-01 Univ Central Florida Res Found Inc PM21 particles to enhance NK cell migration to the bone marrow
CN108617638B (zh) * 2017-03-22 2020-01-24 拜西欧斯（北京）生物技术有限公司 组织和/或细胞冻存保护液及其制备与应用
CN108925548A (zh) * 2017-05-24 2018-12-04 西比曼生物科技（香港）有限公司 一种冻存细胞制剂及细胞复苏方式
CN107012119B (zh) * 2017-05-31 2020-03-17 东莞市保莱生物科技有限公司 一种从骨髓中提取免疫细胞的方法
IL276365B2 (en) 2018-02-01 2023-10-01 Nkmax Co Ltd A method for the production of natural killer cells and a preparation for cancer treatment
CN108404219B (zh) * 2018-02-11 2020-09-29 华中科技大学 一种基于冷冻铸造技术的小口径人工血管及其制备方法
CN112135901A (zh) * 2018-03-01 2020-12-25 格雷戈里奥马拉尼翁医院生物医学研究基金会 获得源自胸腺组织的调节性t细胞的方法及所述细胞作为细胞免疫疗法在免疫系统失调中的用途
WO2019226618A1 (en) * 2018-05-22 2019-11-28 Nantkwest, Inc. Methods and systems for cell bed formation during bioprocessing
JP7072147B2 (ja) * 2018-09-13 2022-05-20 極東製薬工業株式会社 間葉系幹細胞の凍害保護液とその利用
CN114615886A (zh) * 2019-08-29 2022-06-10 得克萨斯大学体系董事会 细胞冷冻保存培养基
CN114929249A (zh) * 2019-11-29 2022-08-19 Nkmax有限公司 产生自然杀伤细胞及其组合物的方法
US12188049B2 (en) 2020-04-14 2025-01-07 Tzu Chi University Methods for mobilizing stem cells
CN112913832A (zh) * 2021-01-27 2021-06-08 河南省华隆生物技术有限公司 一种滋养层细胞的保存方法
EP4316498A4 (en) 2021-03-30 2025-03-26 Kaneka Corporation Trypsin inhibition method, and method for producing cell preparation in which same is used
JP2022159210A (ja) * 2021-03-31 2022-10-17 株式会社カネカ 凍結接着性幹細胞の製造方法
CN113151163A (zh) * 2021-04-23 2021-07-23 优牙生物科技(上海)有限公司 一种使用牙髓干细胞制剂修复子宫内膜损伤的方法
CN113396894A (zh) * 2021-07-06 2021-09-17 南方医科大学南方医院 适用于单位毛囊保存的复合冻存液及其制备方法和应用
CN116649328A (zh) * 2023-05-10 2023-08-29 杭州中赢生物医疗科技有限公司 一种人类活性免疫细胞冻存液及其冻存方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789147A (en) 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
AU2730497A (en) * 1996-04-17 1997-11-07 Case Western Reserve University Cryopreservation and extensive subculturing of human mesenchymal stem cells
AU8005098A (en) 1997-06-06 1998-12-21 Governors Of The University Of Alberta, The Alpha1,3-fucosyltransferase of helicobacter pylori
US6461835B1 (en) 1998-09-03 2002-10-08 The University Of Oklahoma Fucosyltransferases, polynucleotides encoding fucosyltransferases, and transgenic mammal incorporating same
US20060210558A1 (en) 2000-10-18 2006-09-21 Robert Sackstein Hematopoietic cell selectin ligand polypeptides and methods of use thereof
CA2431901A1 (en) * 2000-12-14 2002-06-20 The University Of British Columbia Crystal structures of retaining glycosyltransferases
CA2474968A1 (en) * 2002-01-31 2003-08-07 Asahi Techno Glass Corporation Cryopreservation medium for primate embryo stem cells and cryopreservation method
US7332334B2 (en) * 2003-04-18 2008-02-19 Oklahoma Medical Research Foundation Hematopoietic stem cells treated by in vitro fucosylation and methods of use
WO2005017115A2 (en) * 2003-08-11 2005-02-24 Mount Sinai School Of Medicine Of New York University Cord blood-derived hematopoietic progenitor cells
US20100143969A1 (en) * 2005-03-24 2010-06-10 Neose Technologies, Inc. Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
JP2008539796A (ja) * 2005-05-20 2008-11-20 バイレクシス コーポレイション 初代細胞の形質導入
US8198045B2 (en) * 2006-04-19 2012-06-12 Biogenerix Ag Expression of O-glycosylated therapeutic proteins in prokaryotic microorganisms
EP3336174A1 (en) * 2006-06-02 2018-06-20 Robert Sackstein Compositions and methods for modifying cell surface glycans
WO2009020201A1 (ja) * 2007-08-08 2009-02-12 Kyowa Hakko Kirin Co., Ltd. 単離された細胞集団
ES2627043T3 (es) * 2008-06-09 2017-07-26 Targazyme, Inc. Aumento de la eficacia de la terapia celular incluyendo tratamiento con alfa 1-3 fucoslitransferasa
JP5615509B2 (ja) * 2009-03-31 2014-10-29 北海道公立大学法人 札幌医科大学 フコシル化糖鎖産生細胞用物質送達担体
US8409838B2 (en) * 2009-06-02 2013-04-02 Regeneron Pharmaceuticals, Inc. Fucosylation-deficient cells
US20100311036A1 (en) * 2009-06-09 2010-12-09 University Of South Carolina Methods for Augmentation of Cell Cryopreservation
EP2480671B8 (en) * 2009-09-22 2015-10-28 ProBioGen AG Process for producing molecules containing specialized glycan structures
EP2507627A2 (en) * 2009-12-04 2012-10-10 Momenta Pharmaceuticals, Inc. Antennary fucosylation in glycoproteins from cho cells
CN102648708B (zh) * 2011-02-25 2014-08-13 深圳华大方舟生物技术有限公司 一种用于胚胎或细胞的冷冻液及其用途
CA2954534C (en) * 2014-07-07 2023-04-04 Targazyme, Inc. Manufacture and cryopreservation of fucosylated cells for therapeutic use

Similar Documents

Publication Publication Date Title
JP2022065029A5 (https=)
JP7674963B2 (ja) 凍結防止剤、凍結防止および凍結保存組成物、その使用ならびに凍結保存方法
KR101868653B1 (ko) 줄기 세포 현탁액
López et al. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report
CN112544611B (zh) 细胞冻存剂及细胞的冻存方法
WO2012092420A2 (en) Methods for cryopreserving and encapsulating cells
JP2022084665A (ja) 脂肪由来幹細胞に基づく幹細胞治療
CN103704206B (zh) 胎盘保存液
AU2020383622A1 (en) Immortalized cardiac stem cells for cardiac repair
JP2013233102A (ja) トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液
JP2022552230A (ja) 間葉系幹細胞貯蔵または輸送製剤、およびその作製および使用方法
Okano et al. Therapeutic potential of pluripotent stem cells for cardiac repair after myocardial infarction
Arutyunyan et al. Influence of sucrose on the efficiency of cryopreservation of human umbilical cord-derived multipotent stromal cells with the use of various penetrating cryoprotectants
CN109777767A (zh) 一种促进人源脐带间充质干细胞向成骨细胞分化的诱导方法
Woods et al. Cord blood stem cell cryopreservation
RS66169B1 (sr) Rastvor za konzervaciju, transport i nanošenje matičnih ćelija
CN110547286A (zh) 复合冻存液及其制备方法和应用
Pendyala et al. Cellular cardiomyoplasty and cardiac regeneration
Johnson et al. Therapeutic application of adult stem cells in the heart
JP2013252126A (ja) デキストラン含有肺塞栓形成予防用哺乳動物細胞懸濁液
JP2013223504A (ja) 細胞生存率低下抑制剤
JP2014172899A (ja) バイオ活性化剤およびその組成並びに製法
JP2022159210A (ja) 凍結接着性幹細胞の製造方法
BR102013021202A2 (pt) Processo de produção de células tronco multipotentes e progenitores, células tronco e/ou progenitores, fragmentos de tecidos de nnct e concentrado de células tronco
JP4590041B2 (ja) 臓器保存剤